{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "MXN", "firstTradeDateMilliseconds": 1595597400000, "priceHint": 2, "epsTrailingTwelveMonths": -16.71, "sharesOutstanding": 226070000, "bookValue": 0.539, "fiftyDayAverage": 150.2126, "fiftyDayAverageChange": 86.877396, "fiftyDayAverageChangePercent": 0.5783629, "twoHundredDayAverage": 140.22815, "twoHundredDayAverageChange": 96.86185, "twoHundredDayAverageChangePercent": 0.6907447, "marketCap": 55307640832, "priceToBook": 439.87015, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 237.09, "marketState": "PREPRE", "exchange": "MEX", "shortName": "IMMUNOGEN INC", "longName": "ImmunoGen, Inc.", "messageBoardId": "finmb_29794", "exchangeTimezoneName": "America/Mexico_City", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": -21600000, "market": "mx_market", "esgPopulated": false, "regularMarketChange": 0.0, "regularMarketTime": 1683218674, "regularMarketDayHigh": 0.0, "regularMarketDayRange": "0.0 - 0.0", "regularMarketDayLow": 0.0, "regularMarketVolume": 0, "regularMarketPreviousClose": 237.09, "bid": 0.0, "ask": 237.07, "fullExchangeName": "Mexico", "financialCurrency": "USD", "regularMarketOpen": 0.0, "averageDailyVolume3Month": 36, "averageDailyVolume10Day": 211, "fiftyTwoWeekLowChange": 237.09, "fiftyTwoWeekRange": "0.0 - 237.09", "fiftyTwoWeekHighChange": 0.0, "fiftyTwoWeekHighChangePercent": 0.0, "fiftyTwoWeekLow": 0.0, "fiftyTwoWeekHigh": 237.09, "earningsTimestamp": 1682683200, "earningsTimestampStart": 1690461000, "earningsTimestampEnd": 1690806600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "IMGN.MX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451-1477", "country": "United States", "phone": "781 895 0600", "website": "https://www.immunogen.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian cancer; and a cell-surface protein expressed in various epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers, as well as Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti-FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 277, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mark Joseph Enyedy", "age": 58, "title": "Pres, CEO & Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 1284825, "fmt": "1.28M", "longFmt": "1,284,825"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 780281, "fmt": "780.28k", "longFmt": "780,281"}}, {"maxAge": 1, "name": "Ms. Renee  Lentini", "age": 44, "title": "Interim CFO, VP of Fin. & Chief Accounting Officer", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": {"raw": 430518, "fmt": "430.52k", "longFmt": "430,518"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 243574, "fmt": "243.57k", "longFmt": "243,574"}}, {"maxAge": 1, "name": "Dr. Anna  Berkenblit M.D., MM.Sc", "age": 52, "title": "Sr. VP & Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 717040, "fmt": "717.04k", "longFmt": "717,040"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 429762, "fmt": "429.76k", "longFmt": "429,762"}}, {"maxAge": 1, "name": "Ms. Stacy A. Coen", "age": 51, "title": "Sr. VP & Chief Bus. Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 584042, "fmt": "584.04k", "longFmt": "584,042"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 10100, "fmt": "10.1k", "longFmt": "10,100"}}, {"maxAge": 1, "name": "Dr. Michael J. Vasconcelles M.D., Ph.D.", "age": 59, "title": "Exec. VP of Research, Devel. & Medical Affairs", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 304620, "fmt": "304.62k", "longFmt": "304,620"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Anabel  Chan", "title": "Head of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Daniel S. Char J.D.", "age": 61, "title": "Sr. VP, Chief Legal Officer & Sec.", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Courtney  O'Konek", "title": "Sr. Director of Corp. Communications & Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Audrey  Bergan", "title": "Sr. VP & Chief HR Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Theresa G. Wingrove", "age": 64, "title": "Sr. VP of Regulatory Affairs & Quality", "yearBorn": 1958, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 3, "boardRisk": 3, "compensationRisk": 7, "shareHolderRightsRisk": 5, "overallRisk": 4, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}